[HTML][HTML] Application of pharmacokinetic-pharmacodynamic modeling in drug delivery: development and challenges

H Zou, P Banerjee, SSY Leung, X Yan - Frontiers in pharmacology, 2020 - frontiersin.org
drug discovery and development, is a mathematical approach to study pharmacokinetics (PK),
pharmacodynamics … The PK model is an integration of a modified two-compartment model …

[HTML][HTML] Incorporating pharmacometrics into pharmacoeconomic models: applications from drug development

M Srinivasan, A White, A Chaturvedula… - …, 2020 - Springer
… how integrated pharmacokineticpharmacodynamic–… comprehensive approach to simulate
realistic treatment protocols and relate them to cost effectiveness in early drug development

[HTML][HTML] The importance of pharmacokinetics and pharmacodynamics in antimicrobial drug development and their influence on the success of agents developed to …

ME Palmer, LJ Andrews, TC Abbey… - Frontiers in …, 2022 - frontiersin.org
Frontiers | The importance of pharmacokinetics and pharmacodynamics in antimicrobial drug
development and their influence on the success of agents developed to combat resistant …

Integrating pharmacokinetics and pharmacodynamics in operational research to end tuberculosis

JWC Alffenaar, T Gumbo, KE Dooley… - Clinical Infectious …, 2020 - academic.oup.com
… and most efficacious medicines built upon rapid whole-genome sequencing drug-susceptibility …
actionable knowledge of antibiotic pharmacokinetics (PK) and pharmacodynamics (PD). …

[HTML][HTML] Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development

Y Lai, X Chu, L Di, W Gao, Y Guo, X Liu, C Lu… - … Pharmaceutica Sinica B, 2022 - Elsevier
… As such, the discipline is well integrated into the holistic drug discovery paradigm to optimize
ADME properties of molecules early and select drug candidates for entry into development. …

[HTML][HTML] … of the pharmacokinetics and pharmacodynamics of topiroxostat in humans by integrating the physiologically based pharmacokinetic model with the drug …

Z Luo, G Yu, X Han, T Yang, Y Ji, H Huang… - Biomedicine & …, 2020 - Elsevier
pharmacodynamics of topiroxostat in vivo. This study highlights the important role of the …
model and drug–target residence time model in drug discovery and development process …

[HTML][HTML] Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and phase Ib/IIa studies in patients with extensive …

C Li, L Hart, TK Owonikoko, R Aljumaily… - Cancer Chemotherapy …, 2021 - Springer
… We report integrated analyses of preclinical and clinical data that informed selection of the
recommended Phase II dose (RP2D) used in trilaciclib trials in extensive-stage small cell lung …

[HTML][HTML] Reviewing data integrated for PBPK model development to predict metabolic drug-drug interactions: shifting perspectives and emerging trends

K Abouir, CF Samer, Y Gloor, JA Desmeules… - Frontiers in …, 2021 - frontiersin.org
… in the pharmaceutical industry. At the research and drug development, PBPK has already
proven itself and is now an integral tool in drug discovery and development. It is a good tool for …

[HTML][HTML] Microfluidic organ-on-a-chip system for disease modeling and drug development

Z Li, J Hui, P Yang, H Mao - Biosensors, 2022 - mdpi.com
… These models integrated with various sensors show great potential in simulating the human
… to the fields of pharmacokinetics/pharmacodynamics, nano-medicine, continuous dynamic …

Comprehensive development in organ-on-a-chip technology

X Joseph, V Akhil, A Arathi, PV Mohanan - Journal of Pharmaceutical …, 2022 - Elsevier
… in the body when a new drug molecule is administered as part of the pre… comprehensive
development in the organ-on-a-chip technology, various OOC models and its drug development